Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Non-invasive Prenatal Testing Equipment Market by Type (First Trimester, Second Trimester, Third Trimester, Post-Term), By Application (Hospital, Household) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Non-invasive Prenatal Testing Equipment Market by Type (First Trimester, Second Trimester, Third Trimester, Post-Term), By Application (Hospital, Household) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 282537 4200 Medical Devices & Consumables 377 193 Pages 4.6 (38)
                                          

Market Overview:


The global non-invasive prenatal testing equipment market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for non-invasive prenatal tests, technological advancements in non-invasive prenatal testing equipment, and rising awareness about non-invasive prenatal tests. Based on type, the global non-invasive prenatal testing equipment market can be segmented into first trimester tests, second trimester tests, third trimester tests, and post-term tests.


Global Non-invasive Prenatal Testing Equipment Industry Outlook


Product Definition:


Non-invasive prenatal testing (NIPT) is a term for medical screening procedures that can detect certain genetic disorders in a fetus as early as nine weeks into pregnancy. NIPT equipment includes various technologies used to examine fetal DNA in the mother's blood. The importance of NIPT is that it can provide information about potential genetic disorders much earlier in a pregnancy than traditional prenatal tests, such as an ultrasound or amniocentesis. This allows parents to make more informed decisions about their pregnancies.


First Trimester:


The First Trimester is the earliest stage of pregnancy and it lasts for about four weeks. At this stage, a fertilized egg (ova) has divided into two cells, which are known as the zygote. The zygote then implants in the uterus and continues to grow until completion of seven months gestation or October 6th-10th delivery date.


Second Trimester:


The Second Trimester is the 13-26 weeks of pregnancy. It’s a time when the baby can survive outside the uterus in a sac called amniotic cavity. The second trimester includes two key stages, namely, Gestational Week (GW) and embryonic day (ED). ED marks start of an embryo’s development; it is marked by one cell division and appearance of primitive streak.


Application Insights:


The hospital application segment dominated the global market in 2017. The demand for NIPT is increasing at a rapid pace in hospitals, owing to its benefits such as accurate diagnosis of chromosomal abnormalities and reduction in the number of multiple pregnancies. In addition, growing awareness about prenatal testing among women undergoing fertility treatment at hospitals is expected to drive growth over the forecast period.


Household applications are anticipated to witness significant growth over the forecast period due to rising awareness about available diagnostic options and availability of affordable services by private laboratories across countries worldwide. Increasing adoption of advanced non-invasive prenatal testing equipment by private laboratories across Europe and North America has led to increased penetration into households thereby fueling market growth.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to increasing awareness about prenatal screening, rising adoption of technologically advanced products, and supportive government initiatives. For instance, in the U.S., women are encouraged to undergo free ultrasound scans during their pregnancies as a way of gaining knowledge about fetal development and possible health risks associated with it.


Asia Pacific is expected to witness lucrative growth over the forecast period owing to an increase in demand for maternal care services due to population growth and rise in disposable income levels coupled with growing healthcare expenditure by governments across countries such as China & India & Japan etc.; thereby creating opportunities for market players operating within this region. Moreover, an increase in number of foreign investors investing within this region will also drive regional growth over the forecast period; especially when compared with other regions such as Latin America which has been experiencing economic turmoil recently (last few years).


Growth Factors:


  • Increasing demand for non-invasive prenatal testing equipment due to the increasing incidence of chromosomal abnormalities and genetic disorders.
  • Rising awareness about the benefits of early diagnosis and treatment of genetic disorders through non-invasive prenatal testing equipment.
  • Technological advancements in non-invasive prenatal testing equipment that offer enhanced accuracy and precision in results.
  • Growing demand for single nucleotide polymorphism (SNP) based tests as they are more accurate than other tests for detecting chromosomal abnormalities and genetic disorders.

Scope Of The Report

Report Attributes

Report Details

Report Title

Non-invasive Prenatal Testing Equipment Market Research Report

By Type

First Trimester, Second Trimester, Third Trimester, Post-Term

By Application

Hospital, Household

By Companies

PerkinElmer, Roche, Sequenom, BGI Genomics, Illumina, LifeCodexx, Natera

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

193

Number of Tables & Figures

136

Customization Available

Yes, the report can be customized as per your need.


Global Non-invasive Prenatal Testing Equipment Market Report Segments:

The global Non-invasive Prenatal Testing Equipment market is segmented on the basis of:

Types

First Trimester, Second Trimester, Third Trimester, Post-Term

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Household

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. PerkinElmer
  2. Roche
  3. Sequenom
  4. BGI Genomics
  5. Illumina
  6. LifeCodexx
  7. Natera

Global Non-invasive Prenatal Testing Equipment Market Overview


Highlights of The Non-invasive Prenatal Testing Equipment Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. First Trimester
    2. Second Trimester
    3. Third Trimester
    4. Post-Term
  1. By Application:

    1. Hospital
    2. Household
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Non-invasive Prenatal Testing Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Non-invasive Prenatal Testing Equipment Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Non-invasive prenatal testing equipment is a type of medical device that can be used to detect certain types of abnormalities in a pregnant woman's pregnancy. This equipment can include tests that use ultrasound, blood tests, and other methods.

Some of the major players in the non-invasive prenatal testing equipment market are PerkinElmer, Roche, Sequenom, BGI Genomics, Illumina, LifeCodexx, Natera.

The non-invasive prenatal testing equipment market is expected to grow at a compound annual growth rate of 10.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Non-invasive Prenatal Testing Equipment Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Non-invasive Prenatal Testing Equipment Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Non-invasive Prenatal Testing Equipment Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Non-invasive Prenatal Testing Equipment Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Non-invasive Prenatal Testing Equipment Market Size & Forecast, 2018-2028       4.5.1 Non-invasive Prenatal Testing Equipment Market Size and Y-o-Y Growth       4.5.2 Non-invasive Prenatal Testing Equipment Market Absolute $ Opportunity

Chapter 5 Global Non-invasive Prenatal Testing Equipment Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Non-invasive Prenatal Testing Equipment Market Size Forecast by Type
      5.2.1 First Trimester
      5.2.2 Second Trimester
      5.2.3 Third Trimester
      5.2.4 Post-Term
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Non-invasive Prenatal Testing Equipment Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Non-invasive Prenatal Testing Equipment Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Household
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Non-invasive Prenatal Testing Equipment Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Non-invasive Prenatal Testing Equipment Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Non-invasive Prenatal Testing Equipment Analysis and Forecast
   9.1 Introduction
   9.2 North America Non-invasive Prenatal Testing Equipment Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Non-invasive Prenatal Testing Equipment Market Size Forecast by Type
      9.6.1 First Trimester
      9.6.2 Second Trimester
      9.6.3 Third Trimester
      9.6.4 Post-Term
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Non-invasive Prenatal Testing Equipment Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Household
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Non-invasive Prenatal Testing Equipment Analysis and Forecast
   10.1 Introduction
   10.2 Europe Non-invasive Prenatal Testing Equipment Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Non-invasive Prenatal Testing Equipment Market Size Forecast by Type
      10.6.1 First Trimester
      10.6.2 Second Trimester
      10.6.3 Third Trimester
      10.6.4 Post-Term
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Non-invasive Prenatal Testing Equipment Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Household
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Non-invasive Prenatal Testing Equipment Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Non-invasive Prenatal Testing Equipment Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Non-invasive Prenatal Testing Equipment Market Size Forecast by Type
      11.6.1 First Trimester
      11.6.2 Second Trimester
      11.6.3 Third Trimester
      11.6.4 Post-Term
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Non-invasive Prenatal Testing Equipment Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Household
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Non-invasive Prenatal Testing Equipment Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Non-invasive Prenatal Testing Equipment Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Non-invasive Prenatal Testing Equipment Market Size Forecast by Type
      12.6.1 First Trimester
      12.6.2 Second Trimester
      12.6.3 Third Trimester
      12.6.4 Post-Term
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Non-invasive Prenatal Testing Equipment Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Household
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Non-invasive Prenatal Testing Equipment Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Non-invasive Prenatal Testing Equipment Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Non-invasive Prenatal Testing Equipment Market Size Forecast by Type
      13.6.1 First Trimester
      13.6.2 Second Trimester
      13.6.3 Third Trimester
      13.6.4 Post-Term
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Non-invasive Prenatal Testing Equipment Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Household
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Non-invasive Prenatal Testing Equipment Market: Competitive Dashboard
   14.2 Global Non-invasive Prenatal Testing Equipment Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 PerkinElmer
      14.3.2 Roche
      14.3.3 Sequenom
      14.3.4 BGI Genomics
      14.3.5 Illumina
      14.3.6 LifeCodexx
      14.3.7 Natera

Our Trusted Clients

Contact Us